BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 26446603)

  • 1. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
    Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
    J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope.
    Ruhl M; Chhatwal P; Strathmann H; Kuntzen T; Bankwitz D; Skibbe K; Walker A; Heinemann FM; Horn PA; Allen TM; Hoffmann D; Pietschmann T; Timm J
    J Virol; 2012 Jan; 86(2):991-1000. PubMed ID: 22072759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8 epitope escape and reversion in acute HCV infection.
    Timm J; Lauer GM; Kavanagh DG; Sheridan I; Kim AY; Lucas M; Pillay T; Ouchi K; Reyor LL; Schulze zur Wiesch J; Gandhi RT; Chung RT; Bhardwaj N; Klenerman P; Walker BD; Allen TM
    J Exp Med; 2004 Dec; 200(12):1593-604. PubMed ID: 15611288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential escape of HCV from CD8
    Xia Y; Pan W; Ke X; Skibbe K; Walker A; Hoffmann D; Lu Y; Yang X; Feng X; Tong Q; Timm J; Yang D
    J Viral Hepat; 2019 Jan; 26(1):73-82. PubMed ID: 30260541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of sequence variation in a dominant HLA-A*02-restricted epitope in hepatitis C virus on priming and cross-reactivity of CD8+ T cells.
    Ziegler S; Skibbe K; Walker A; Ke X; Heinemann FM; Heinold A; Mok JY; van Esch WJ; Yang D; Wölfl M; Timm J
    J Virol; 2014 Oct; 88(19):11080-90. PubMed ID: 25008925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.
    Fytili P; Dalekos GN; Schlaphoff V; Suneetha PV; Sarrazin C; Zauner W; Zachou K; Berg T; Manns MP; Klade CS; Cornberg M; Wedemeyer H
    Vaccine; 2008 Jul; 26(31):3818-26. PubMed ID: 18582999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope.
    Neumann-Haefelin C; Timm J; Schmidt J; Kersting N; Fitzmaurice K; Oniangue-Ndza C; Kemper MN; Humphreys I; McKiernan S; Kelleher D; Lohmann V; Bowness P; Huzly D; Rosen HR; Kim AY; Lauer GM; Allen TM; Barnes E; Roggendorf M; Blum HE; Thimme R
    Hepatology; 2010 Jan; 51(1):54-62. PubMed ID: 20034048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
    Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P
    Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escape from HLA-B*08-restricted CD8 T cells by hepatitis C virus is associated with fitness costs.
    Salloum S; Oniangue-Ndza C; Neumann-Haefelin C; Hudson L; Giugliano S; aus dem Siepen M; Nattermann J; Spengler U; Lauer GM; Wiese M; Klenerman P; Bright H; Scherbaum N; Thimme R; Roggendorf M; Viazov S; Timm J
    J Virol; 2008 Dec; 82(23):11803-12. PubMed ID: 18815309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
    Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations.
    Neumann-Haefelin C; Oniangue-Ndza C; Kuntzen T; Schmidt J; Nitschke K; Sidney J; Caillet-Saguy C; Binder M; Kersting N; Kemper MW; Power KA; Ingber S; Reyor LL; Hills-Evans K; Kim AY; Lauer GM; Lohmann V; Sette A; Henn MR; Bressanelli S; Thimme R; Allen TM
    Hepatology; 2011 Oct; 54(4):1157-66. PubMed ID: 22006856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical linkage analysis of substitutions in patient-derived sequences of genotype 1a hepatitis C virus nonstructural protein 3 exposes targets for immunogen design.
    Quadeer AA; Louie RH; Shekhar K; Chakraborty AK; Hsing IM; McKay MR
    J Virol; 2014 Jul; 88(13):7628-44. PubMed ID: 24760894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T-cell response promotes evolution of hepatitis C virus nonstructural proteins.
    Ruhl M; Knuschke T; Schewior K; Glavinic L; Neumann-Haefelin C; Chang DI; Klein M; Heinemann FM; Tenckhoff H; Wiese M; Horn PA; Viazov S; Spengler U; Roggendorf M; Scherbaum N; Nattermann J; Hoffmann D; Timm J;
    Gastroenterology; 2011 Jun; 140(7):2064-73. PubMed ID: 21376049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population level.
    Neumann-Haefelin C; Frick DN; Wang JJ; Pybus OG; Salloum S; Narula GS; Eckart A; Biezynski A; Eiermann T; Klenerman P; Viazov S; Roggendorf M; Thimme R; Reiser M; Timm J
    J Virol; 2008 Apr; 82(7):3438-51. PubMed ID: 18216107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naturally occurring CD4+ T-cell epitope variants act as altered peptide ligands leading to impaired helper T-cell responses in hepatitis C virus infection.
    Cusick MF; Yang M; Gill JC; Eckels DD
    Hum Immunol; 2011 May; 72(5):379-85. PubMed ID: 21377503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus mutation affects proteasomal epitope processing.
    Seifert U; Liermann H; Racanelli V; Halenius A; Wiese M; Wedemeyer H; Ruppert T; Rispeter K; Henklein P; Sijts A; Hengel H; Kloetzel PM; Rehermann B
    J Clin Invest; 2004 Jul; 114(2):250-9. PubMed ID: 15254592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An extensive antigenic footprint underpins immunodominant TCR adaptability against a hypervariable viral determinant.
    Nivarthi UK; Gras S; Kjer-Nielsen L; Berry R; Lucet IS; Miles JJ; Tracy SL; Purcell AW; Bowden DS; Hellard M; Rossjohn J; McCluskey J; Bharadwaj M
    J Immunol; 2014 Dec; 193(11):5402-13. PubMed ID: 25355921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8
    Karimzadeh H; Kiraithe MM; Kosinska AD; Glaser M; Fiedler M; Oberhardt V; Salimi Alizei E; Hofmann M; Mok JY; Nguyen M; van Esch WJE; Budeus B; Grabowski J; Homs M; Olivero A; Keyvani H; Rodríguez-Frías F; Tabernero D; Buti M; Heinold A; Alavian SM; Bauer T; Schulze Zur Wiesch J; Raziorrouh B; Hoffmann D; Smedile A; Rizzetto M; Wedemeyer H; Timm J; Antes I; Neumann-Haefelin C; Protzer U; Roggendorf M
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.